Retinol-binding protein 4 (RBP-4) not only has GO term annotations for its involvement in visual perception and the metabolism of retinol, but it has been described as a potential target in treating atrophic AMD and Stargardt's disease (45). The gene discussed is RBP4; the disease is Stargardt disease.